A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese Subjects.

Liu, Hui; Wang, Feng; Ji, Yongjia; Ma, Tianyang; Li, Hongying; Linnebjerg, Helle; Chua, Laiyi; Tham, Lai San; Yu, Yerong

Liu, Hui; Wang, Feng; Ji, Yongjia; Ma, Tianyang; Li, Hongying; Linnebjerg, Helle; Chua, Laiyi; Tham, Lai San; Yu, Yerong.

Afiliação

Liu H; Department of General Practice, West China Hospital of Sichuan University, Chengdu, China.
Wang F; Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China.
Ji Y; Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China.
Ma T; Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China.
Li H; Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China.
Linnebjerg H; Eli Lilly and Company, Indianapolis, Indiana, USA.
Chua L; Lilly Centre for Clinical Pharmacology, Singapore, Singapore.
Tham LS; Lilly Centre for Clinical Pharmacology, Singapore, Singapore.
Yu Y; Department of Endocrinology, West China Hospital of Sichuan University, Chengdu, China.

Clin Pharmacol Drug Dev ; 10(12): 1452-1459, 2021 12.

Article em En | MEDLINE | ID: mdl-34410042

Assuntos

Glucose; Hipoglicemiantes; Disponibilidade Biológica; Glicemia/metabolismo; China; Estudos Cross-Over; Técnica Clamp de Glucose; Humanos; Insulina Glargina

Palavras-chave

LY2963016; healthy Chinese subjects; insulin glargine; relative bioavailability

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glucose / Hipoglicemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glucose / Hipoglicemiantes Idioma: En Ano de publicação: 2021 Tipo de documento: Article